These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 8593738
1. New drugs in the treatment of heart failure. Brown L. Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):829-32. PubMed ID: 8593738 [Abstract] [Full Text] [Related]
2. Vasodilators and inotropic agents in the treatment of congestive heart failure. Francis GS. Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651 [Abstract] [Full Text] [Related]
7. [New inotropic vasodilators: what is their role in the long-term treatment of heart failure?]. Padrini R. G Ital Cardiol; 1987 Mar; 17(3):259-63. PubMed ID: 3301506 [No Abstract] [Full Text] [Related]
8. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators. Boden WE, Ziesche S, Carson PE, Conrad CH, Syat D, Cohn JN. Am J Cardiol; 1996 May 15; 77(12):1078-82. PubMed ID: 8644661 [Abstract] [Full Text] [Related]
12. [Treatment of resistant cardiac failure; vasodilators and new inotropic drugs]. Herziano H, Gil I, Almog C. Harefuah; 1980 Jun 15; 98(11-12):517-8. PubMed ID: 7203196 [No Abstract] [Full Text] [Related]
13. Medical management of chronic heart failure: inotropic, vasodilator, or inodilator drugs? Lang R. Am Heart J; 1990 Dec 15; 120(6 Pt 2):1558-64. PubMed ID: 1978981 [Abstract] [Full Text] [Related]
14. Pathophysiology and current therapy of congestive heart failure. Parmley WW. J Am Coll Cardiol; 1989 Mar 15; 13(4):771-85. PubMed ID: 2647811 [Abstract] [Full Text] [Related]